Anlotinib plus penpulimab has demonstrated encouraging activity and safety in a phase 2 study. In this phase 3 trial, we aimed to assess whether the combination of anlotinib plus penpulimab improved ...

A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to evaluate the efficacy of ...

James Gunn, the director of upcoming Superman and Guardian of the Galaxy trilogy, revealed that he knew nothing about one aspect of MCU.

Krystal Biotech announced the first patient dosing in its Phase 1/2 trial of KB801 for neurotrophic keratitis.

Splitgate 2 developer 1047 Games has confirmed an undisclosed number of layoffs, with the co-founders of the studio opting not to take salaries as they bid to turn things around.

A complete breakdown of the MLB All-Star Game voting leaders with the first phase complete and the finalists now announced.

Invivyd reports positive Phase 1/2 results for VYD2311, showing safety, long half-life, and potential for effective COVID-19 prevention.

Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 liver disease study.

DENALI-1 is a multicenter phase 1/2 dose-escalation clinical study to evaluate the safety and efficacy of A2B395, an allogeneic logic-gated CAR T cell therapy, in participants with solid tumors ...

The 2025 MLB All-Star Game is just a few short weeks away, with the baseball world set to converge on Truist Park in Atlanta for the annual exhibition of the game's best and brightest.

Lineage Cell Therapeutics recently announced 36-month results from a phase 1/2a clinical study (NCT02286089) of RG6501 (OpRegen) for the treatment of geographic atrophy (GA), secondary to age-related ...